Skip to main content
. 2021 Aug 17;11:16622. doi: 10.1038/s41598-021-96169-y

Figure 1.

Figure 1

Phenotypic resistance to antimicrobial agents detected among isolates of (A) E. coli, (B) K. pneumoniae, (C*) ACB complex and (D**) MRSA. Abbreviations for antimicrobial agents: TEM temocillin, PIP piperacillin, TZP piperacillin-tazobactam, CTX cefotaxime; CAZ ceftazidime; CZA ceftazidime-avibactam; C/T ceftolozane-tazobactam; IMP imipenem, MEM meropenem, AMK amikacin, TGC tigecycline, CIP ciprofloxacin, LVX levofloxacin, CHL chloramphenicol, SXT sulfamethoxazole-trimethoprim, FOF fosfomycin, CST colistin, AMP ampicillin, GEN gentamicin; OXA oxacillin, TEC teicoplanin, PEN-G penicillin G, FA fusidic acid, LZD linezolid, DAP daptomycin, CPT ceftaroline,, VAN vancomycin, RIF rifampicin, MUP mupirocin, FOX cefoxitin; MXF moxifloxacin, CLI clindamycin; ERY erythromycin, Q-D synercid (quinupristin-dalfopristin). *Species of the ACB complex are considered intrinsically resistant to temocillin, cefotaxime, chloramphenicol and fosfomycin. **MRSA is considered intrinsically resistant to ampicillin, oxacillin, penicillin-G and cefoxitin.